Home Tools
Log in
Cart

Search Result

Search Results for " pioglitazone "

Targets

9

Compounds

Cat No. Product Name Synonyms Targets
T0214 Pioglitazone U 72107 Ferroptosis , PPAR
Pioglitazone (U 72107) is an insulin sensitizing agent and thiazolidinedione that is indicated for the treatment of type 2 diabetes. Pioglitazone has been linked to rare instances of acute liver injury.
T0214L Pioglitazone hydrochloride U-72107E,AD 4833,U 72107A,Pioglitazone HCl Ferroptosis , PPAR
Pioglitazone hydrochloride (AD 4833) is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity.
T12479 Pioglitazone-d4 U 72107 D4 Others
Pioglitazone D4 is a deuterium labeled Pioglitazone. Pioglitazone is a agonist of PPARγ .
T61836 Pioglitazone potassium
Pioglitazone potassium (U 72107) is an orally active and selective agonist of peroxisome proliferator-activated receptor gamma (PPARγ). It demonstrates high affinity binding to the ligand-binding domain of PPARγ, with an...
T20465 Ketopioglitazone Keto pioglitazone,Pioglitazone metabolite M3
Ketopioglitazone is an active metabolite of pioglitazone.
T27210 DRX-065 DRX 065,DRX065,deuterated R-enantiomer of pioglitazone
DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects,...
T15736 Leriglitazone Hydroxypioglitazone Others
Leriglitazone, a metabolite of pioglitazone, binds to the PPARγ C-terminal ligand-binding domain (Ki: 1.2 μM) and induces transcriptional efficacy of the PPARγ (EC50: 680 nM). Leriglitazone PioOH is a PPARγ agonist, stab...
T73842 Leriglitazone hydrochloride
Leriglitazone (Hydroxypioglitazone) hydrochloride, a metabolite of pioglitazone. Leriglitazone (Hydroxypioglitazone) hydrochloride PioOH is a PPARγ agonist, stabilizes the PPARγ activation function-2 (AF-2) co-activator ...
T28542 Rivoglitazone HCl CI-1037,CI1037,CS011,CS-011,CI 1037
Rivoglitazone, also known as CI-1037; CS-011; DE-101; R-119702; Rivo, is a peroxisome proliferator-activated receptor γ agonist (PARPγ agonist) potentially for the treatment of type 2 diabetes. Rivoglitazone has been sho...
TargetMol